“Supreme Court to rule on FDA approval of abortion drug mifepristone; Oral arguments are scheduled for Tuesday”: Shannon Bream and Bill Mears of Fox News has this report.

Sandhya Raman and Michael Macagnone of Roll Call report that “Supreme Court to hear oral arguments on medication abortion drug; Justices on Tuesday consider challenge that could limit access to mifepristone.”

And The Washington Post has published an editorial titled “The Supreme Court’s latest abortion case has an obvious answer.”

“Former Justice Stephen Breyer reflects on ‘unfortunate’ Supreme Court leak before Dobbs abortion ruling; In an interview with NBC’s ‘Meet the Press,’ Breyer was asked whether the justices had discussed a compromise 15-week abortion ban”: Alexandra Marquez of NBC News has this report.

“McConnell Stole a Supreme Court Seat. Is That the Norm Now?” Ed Kilgore has this post at the “Intelligencer” blog of New York magazine.

“Rare All-Female Lineup to Argue Supreme Court Abortion Pill Case; Men vastly outnumber women at high court lectern; Number of female advocates unusually high this term”: Kimberly Strawbridge Robinson of Bloomberg Law has this report.

“How rightwing groups used junk science to get an abortion case before the US supreme court; Anti-abortion researchers ‘exaggerate’ and ‘obfuscate’ in their scientific papers — but by the time they’re published, it’s too late”: Jessica Glenza of The Guardian has this report.

“What happens when an AG dares to investigate Leonard Leo’s network; Brian Schwalb’s probe followed a complaint that nonprofit groups associated with the judicial activist violated their tax status”: Heidi Przybyla of Politico has this report.